Literature DB >> 15273122

Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters.

Mahir Karababa1, Alix T Coste, Bénédicte Rognon, Jacques Bille, Dominique Sanglard.   

Abstract

Azole resistance in Candida albicans can be due to upregulation of multidrug transporters belonging to ABC (ATP-binding cassette) transporters (CDR1 and CDR2) or major facilitators (CaMDR1). Upregulation of these genes can also be achieved by exposure to fluphenazine, resulting in specific upregulation of CDR1 and CDR2 and by exposure to benomyl, resulting in specific CaMDR1 upregulation. In this study, these two different states of gene upregulation were used to determine coregulated genes that often share similar functions or similar regulatory regions. The transcript profiles of a laboratory strain exposed to these drugs were therefore determined and compared with those of two matched pairs of azole-susceptible and -resistant strains expressing CDR1 and CDR2 (CDR strains) or CaMDR1 (MDR isolates). The results obtained revealed that, among 42 commonly regulated genes (8.6% of all regulated genes) between fluphenazine-exposed cells and CDR isolates, the most upregulated were CDR1 and CDR2 as expected, but also IFU5, RTA3 (which encodes putative membrane proteins), HSP12 (which encodes heat shock protein), and IPF4065 (which is potentially involved in stress response). Interestingly, all but HSP12 and IPF4065 contain a putative cis-acting drug responsive element in their promoters. Among the 57 genes (11.5% of all regulated genes) commonly regulated between benomyl-exposed cells and MDR isolates, the most upregulated were CaMDR1 as expected but also genes with oxido-reductive functions such as IFD genes, IPF5987, GRP2 (all belonging to the aldo-keto reductase family), IPF7817 [NAD(P)H oxido-reductase], and IPF17186. Taken together, these results show that in vitro drug-induced gene expression only partially mimics expression profiles observed in azole-resistant clinical strains. Upregulated genes in both drug-exposed conditions and clinical strains are drug resistance genes but also genes that could be activated under cell damage conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273122      PMCID: PMC478486          DOI: 10.1128/AAC.48.8.3064-3079.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Population genomics of drug resistance in Candida albicans.

Authors:  Leah E Cowen; André Nantel; Malcolm S Whiteway; David Y Thomas; Daniel C Tessier; Linda M Kohn; James B Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

Review 2.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

3.  Stress-induced gene expression in Candida albicans: absence of a general stress response.

Authors:  Brice Enjalbert; André Nantel; Malcolm Whiteway
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

4.  The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.

Authors:  D Sanglard; F Ischer; D Calabrese; P A Majcherczyk; J Bille
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance.

Authors:  Michelle de Micheli; Jacques Bille; Christoph Schueller; Dominique Sanglard
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

6.  Isogenic strain construction and gene mapping in Candida albicans.

Authors:  W A Fonzi; M Y Irwin
Journal:  Genetics       Date:  1993-07       Impact factor: 4.562

7.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

8.  Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans.

Authors:  B Hube; M Monod; D A Schofield; A J Brown; N A Gow
Journal:  Mol Microbiol       Date:  1994-10       Impact factor: 3.501

9.  Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae.

Authors:  Ameeta K Agarwal; P David Rogers; Scott R Baerson; Melissa R Jacob; Katherine S Barker; John D Cleary; Larry A Walker; Dale G Nagle; Alice M Clark
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

10.  Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates.

Authors:  P David Rogers; Katherine S Barker
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

View more
  69 in total

1.  Transcriptional profiling of azole-resistant Candida parapsilosis strains.

Authors:  A P Silva; I M Miranda; A Guida; J Synnott; R Rocha; R Silva; A Amorim; C Pina-Vaz; G Butler; A G Rodrigues
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Non-glucan attached proteins of Candida albicans biofilm formed on various surfaces.

Authors:  Govindsamy Vediyappan; W Lajean Chaffin
Journal:  Mycopathologia       Date:  2006-01       Impact factor: 2.574

3.  In vivo fluconazole pharmacodynamics and resistance development in a previously susceptible Candida albicans population examined by microbiologic and transcriptional profiling.

Authors:  D Andes; A Lepak; J Nett; L Lincoln; K Marchillo
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

4.  Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole.

Authors:  Márcia Eliana da Silva Ferreira; Iran Malavazi; Marcela Savoldi; Axel A Brakhage; Maria Helena S Goldman; H Stanley Kim; William C Nierman; Gustavo H Goldman
Journal:  Curr Genet       Date:  2006-04-19       Impact factor: 3.886

5.  Anticandidal activity of hetero-dinuclear copper(II) Mn(II) Schiff base and its potential action of the mechanism.

Authors:  Bekir Mustafa Yoğurtçu; Selami Demirci; Ayşegül Doğan; Ayla Burçin Asutay; Fikrettin Şahin
Journal:  World J Microbiol Biotechnol       Date:  2017-10-27       Impact factor: 3.312

Review 6.  Candida albicans cell wall proteins.

Authors:  W LaJean Chaffin
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

7.  Aneuploid chromosomes are highly unstable during DNA transformation of Candida albicans.

Authors:  Kelly Bouchonville; Anja Forche; Karen E S Tang; Anna Selmecki; Judith Berman
Journal:  Eukaryot Cell       Date:  2009-08-21

8.  Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains.

Authors:  Sabrina Schubert; P David Rogers; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

Review 9.  Coevolution of morphology and virulence in Candida species.

Authors:  Delma S Thompson; Patricia L Carlisle; David Kadosh
Journal:  Eukaryot Cell       Date:  2011-07-15

10.  SAGA/ADA complex subunit Ada2 is required for Cap1- but not Mrr1-mediated upregulation of the Candida albicans multidrug efflux pump MDR1.

Authors:  Bernardo Ramírez-Zavala; Selene Mogavero; Eva Schöller; Christoph Sasse; P David Rogers; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.